Form 8-K - Current report:
SEC Accession No. 0001193125-21-192308
Filing Date
2021-06-17
Accepted
2021-06-16 18:16:32
Documents
12
Period of Report
2021-06-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d60583d8k.htm   iXBRL 8-K 30657
  Complete submission text file 0001193125-21-192308.txt   155050

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20210616.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20210616_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20210616_pre.xml EX-101.PRE 11423
5 EXTRACTED XBRL INSTANCE DOCUMENT d60583d8k_htm.xml XML 3382
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 211022674
SIC: 2834 Pharmaceutical Preparations